ended 30 June 2017 which has been reviewed by auditor as follows: Table1: Financial Summary for the three-month of year 2016 and 2017 Unit: Million Baht Q2’2017 Q2’2016 Increase (Decrease) % Change Sales
ended 30 June 2017 which has been reviewed by auditor as follows: Table1: Financial Summary for the three-month of year 2016 and 2017 Unit: Million Baht Q2’2017 Q2’2016 Increase (Decrease) % Change Sales
or up by 4.11% and net profit of 1,248.47 million Baht, an increase of 202.25 million Baht or up by 19.33%. This was the result of our ability to control and manage expenses effectively, together with
increase of Baht 116.44 million or up by 8.52% over the same period last year. The main reasons include: 1. Total revenues were Baht 16,375.47 million, a decrease of Baht 118.48 million or down by 0.72
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the
of June 30, 2019 at 92.55 million baht, compare with the same period of previous year with amount of 93.21 million baht which decrease by 0.66 million baht or 0.71% decrease, which resulted from
. Other derivatives liabilities 18. Provision 19. Other liabilities Total liabilities Shareholders’ equity 20. Share capital 20.1 Authorized share capital 20.2 Issued and paid-up share capital 21. Stock
Issued and paid-up share capital 21. Stock rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments) 25
capital 20.2 Issued and paid-up share capital 21. Stock rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments
. Income In 2019, the Company's total revenues were 1,225.29 million Baht, a decrease of 1,483.35 million Baht or 54.76% from the same period last year. The main factor of the decrease revenue came from the